NanJing Pharmaceutical Co Ltd
SSE:600713
Income Statement
Earnings Waterfall
NanJing Pharmaceutical Co Ltd
Revenue
|
53.3B
CNY
|
Cost of Revenue
|
-50.1B
CNY
|
Gross Profit
|
3.3B
CNY
|
Operating Expenses
|
-1.8B
CNY
|
Operating Income
|
1.5B
CNY
|
Other Expenses
|
-928.4m
CNY
|
Net Income
|
565.7m
CNY
|
Income Statement
NanJing Pharmaceutical Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
18 655
N/A
|
19 236
+3%
|
19 828
+3%
|
20 505
+3%
|
21 311
+4%
|
22 076
+4%
|
22 720
+3%
|
23 327
+3%
|
24 010
+3%
|
24 813
+3%
|
25 490
+3%
|
25 786
+1%
|
26 156
+1%
|
26 721
+2%
|
26 831
+0%
|
27 253
+2%
|
27 453
+1%
|
28 810
+5%
|
29 885
+4%
|
30 473
+2%
|
31 608
+4%
|
31 303
-1%
|
32 936
+5%
|
34 716
+5%
|
36 399
+5%
|
37 156
+2%
|
37 209
+0%
|
37 514
+1%
|
38 538
+3%
|
39 817
+3%
|
42 113
+6%
|
43 442
+3%
|
44 140
+2%
|
45 123
+2%
|
45 739
+1%
|
47 167
+3%
|
49 163
+4%
|
50 222
+2%
|
52 603
+5%
|
53 624
+2%
|
53 332
-1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(17 371)
|
(18 015)
|
(18 597)
|
(19 239)
|
(20 011)
|
(20 742)
|
(21 369)
|
(21 960)
|
(22 624)
|
(23 350)
|
(24 039)
|
(24 298)
|
(24 645)
|
(25 152)
|
(25 270)
|
(25 641)
|
(25 793)
|
(26 958)
|
(27 999)
|
(28 528)
|
(29 614)
|
(29 235)
|
(30 820)
|
(32 480)
|
(34 041)
|
(34 699)
|
(34 849)
|
(35 127)
|
(36 055)
|
(37 297)
|
(39 529)
|
(40 781)
|
(41 433)
|
(42 190)
|
(42 819)
|
(44 171)
|
(46 135)
|
(46 969)
|
(49 378)
|
(50 391)
|
(50 076)
|
|
Gross Profit |
1 285
N/A
|
1 221
-5%
|
1 232
+1%
|
1 266
+3%
|
1 300
+3%
|
1 334
+3%
|
1 350
+1%
|
1 366
+1%
|
1 385
+1%
|
1 463
+6%
|
1 451
-1%
|
1 488
+3%
|
1 512
+2%
|
1 568
+4%
|
1 562
0%
|
1 613
+3%
|
1 661
+3%
|
1 853
+12%
|
1 887
+2%
|
1 947
+3%
|
1 995
+2%
|
2 068
+4%
|
2 117
+2%
|
2 237
+6%
|
2 359
+5%
|
2 457
+4%
|
2 361
-4%
|
2 387
+1%
|
2 483
+4%
|
2 520
+1%
|
2 584
+3%
|
2 661
+3%
|
2 707
+2%
|
2 934
+8%
|
2 920
0%
|
2 997
+3%
|
3 027
+1%
|
3 252
+7%
|
3 225
-1%
|
3 232
+0%
|
3 256
+1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(1 078)
|
(906)
|
(891)
|
(930)
|
(933)
|
(932)
|
(912)
|
(916)
|
(909)
|
(983)
|
(975)
|
(1 001)
|
(1 019)
|
(1 011)
|
(958)
|
(978)
|
(993)
|
(1 214)
|
(1 233)
|
(1 225)
|
(1 272)
|
(1 309)
|
(1 274)
|
(1 350)
|
(1 415)
|
(1 513)
|
(1 398)
|
(1 392)
|
(1 433)
|
(1 508)
|
(1 448)
|
(1 471)
|
(1 462)
|
(1 634)
|
(1 556)
|
(1 598)
|
(1 639)
|
(1 971)
|
(1 771)
|
(1 752)
|
(1 762)
|
|
Selling, General & Administrative |
(949)
|
(812)
|
(882)
|
(892)
|
(892)
|
(838)
|
(876)
|
(881)
|
(874)
|
(864)
|
(926)
|
(951)
|
(974)
|
(901)
|
(950)
|
(952)
|
(967)
|
(1 110)
|
(1 166)
|
(1 193)
|
(1 230)
|
(1 149)
|
(1 282)
|
(1 330)
|
(1 407)
|
(1 316)
|
(1 377)
|
(1 392)
|
(1 439)
|
(1 329)
|
(1 451)
|
(1 468)
|
(1 453)
|
(1 461)
|
(1 544)
|
(1 585)
|
(1 622)
|
(1 605)
|
(1 764)
|
(1 755)
|
(1 763)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(1)
|
(6)
|
(8)
|
(5)
|
(11)
|
(11)
|
(12)
|
(7)
|
(16)
|
(15)
|
(14)
|
(8)
|
(17)
|
(19)
|
(23)
|
(12)
|
(21)
|
(24)
|
(26)
|
(18)
|
(31)
|
(32)
|
(34)
|
|
Depreciation & Amortization |
0
|
(87)
|
0
|
0
|
0
|
(89)
|
0
|
0
|
0
|
(105)
|
0
|
0
|
0
|
(94)
|
0
|
0
|
0
|
(106)
|
0
|
0
|
0
|
(122)
|
0
|
0
|
0
|
(140)
|
0
|
0
|
0
|
(151)
|
0
|
0
|
0
|
(156)
|
0
|
0
|
0
|
(264)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(130)
|
(7)
|
(9)
|
(39)
|
(41)
|
(5)
|
(35)
|
(36)
|
(36)
|
(15)
|
(50)
|
(49)
|
(44)
|
(14)
|
(10)
|
(27)
|
(27)
|
4
|
(64)
|
(27)
|
(35)
|
(33)
|
19
|
(8)
|
5
|
(51)
|
(6)
|
13
|
18
|
(19)
|
20
|
16
|
14
|
(4)
|
9
|
11
|
10
|
(84)
|
24
|
34
|
35
|
|
Operating Income |
206
N/A
|
315
+53%
|
340
+8%
|
336
-1%
|
366
+9%
|
401
+10%
|
437
+9%
|
449
+3%
|
476
+6%
|
480
+1%
|
476
-1%
|
487
+2%
|
492
+1%
|
558
+13%
|
601
+8%
|
632
+5%
|
665
+5%
|
638
-4%
|
653
+2%
|
720
+10%
|
722
+0%
|
759
+5%
|
841
+11%
|
886
+5%
|
942
+6%
|
944
+0%
|
962
+2%
|
994
+3%
|
1 049
+6%
|
1 012
-4%
|
1 135
+12%
|
1 189
+5%
|
1 245
+5%
|
1 300
+4%
|
1 364
+5%
|
1 398
+3%
|
1 389
-1%
|
1 281
-8%
|
1 454
+13%
|
1 480
+2%
|
1 494
+1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(217)
|
(219)
|
(214)
|
(223)
|
(244)
|
(279)
|
(198)
|
(173)
|
(159)
|
(204)
|
(213)
|
(216)
|
(213)
|
(212)
|
(233)
|
(251)
|
(269)
|
(283)
|
(312)
|
(328)
|
(339)
|
(313)
|
(367)
|
(390)
|
(420)
|
(417)
|
(500)
|
(514)
|
(501)
|
(402)
|
(440)
|
(460)
|
(494)
|
(521)
|
(544)
|
(529)
|
(507)
|
(371)
|
(486)
|
(493)
|
(511)
|
|
Non-Reccuring Items |
0
|
19
|
0
|
0
|
0
|
58
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
1
|
0
|
28
|
28
|
58
|
89
|
61
|
94
|
34
|
34
|
34
|
17
|
2
|
71
|
71
|
56
|
66
|
14
|
17
|
16
|
67
|
77
|
74
|
79
|
24
|
6
|
6
|
1
|
|
Gain/Loss on Disposition of Assets |
0
|
22
|
0
|
(1)
|
0
|
16
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
120
|
(9)
|
0
|
(2)
|
1
|
8
|
19
|
18
|
9
|
12
|
13
|
16
|
18
|
(7)
|
(10)
|
(12)
|
(6)
|
(8)
|
(21)
|
(21)
|
(24)
|
(4)
|
(2)
|
(3)
|
67
|
61
|
57
|
57
|
(15)
|
2
|
2
|
3
|
7
|
(7)
|
(10)
|
(16)
|
(23)
|
(28)
|
(30)
|
(27)
|
(29)
|
|
Pre-Tax Income |
109
N/A
|
129
+18%
|
124
-4%
|
108
-13%
|
121
+12%
|
204
+69%
|
257
+26%
|
294
+14%
|
326
+11%
|
271
-17%
|
277
+2%
|
288
+4%
|
298
+3%
|
340
+14%
|
360
+6%
|
399
+11%
|
420
+5%
|
405
-4%
|
408
+1%
|
430
+5%
|
451
+5%
|
476
+6%
|
506
+6%
|
528
+4%
|
608
+15%
|
589
-3%
|
591
+0%
|
609
+3%
|
589
-3%
|
678
+15%
|
711
+5%
|
749
+5%
|
773
+3%
|
839
+8%
|
887
+6%
|
927
+5%
|
937
+1%
|
906
-3%
|
944
+4%
|
966
+2%
|
956
-1%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(75)
|
(63)
|
(58)
|
(46)
|
(35)
|
(52)
|
(61)
|
(73)
|
(86)
|
(78)
|
(80)
|
(86)
|
(87)
|
(101)
|
(108)
|
(124)
|
(128)
|
(120)
|
(124)
|
(115)
|
(130)
|
(130)
|
(135)
|
(143)
|
(152)
|
(157)
|
(161)
|
(174)
|
(173)
|
(208)
|
(213)
|
(221)
|
(226)
|
(228)
|
(240)
|
(195)
|
(195)
|
(190)
|
(196)
|
(264)
|
(263)
|
|
Income from Continuing Operations |
33
|
65
|
66
|
62
|
86
|
152
|
195
|
220
|
239
|
193
|
196
|
201
|
210
|
239
|
251
|
275
|
293
|
284
|
285
|
315
|
320
|
346
|
370
|
384
|
455
|
432
|
430
|
435
|
417
|
470
|
499
|
529
|
547
|
611
|
646
|
732
|
743
|
716
|
748
|
702
|
693
|
|
Income to Minority Interest |
(1)
|
(27)
|
(22)
|
(17)
|
(21)
|
(24)
|
(29)
|
(36)
|
(39)
|
(36)
|
(38)
|
(44)
|
(47)
|
(58)
|
(61)
|
(64)
|
(67)
|
(52)
|
(46)
|
(55)
|
(62)
|
(82)
|
(98)
|
(98)
|
(94)
|
(85)
|
(78)
|
(75)
|
(82)
|
(94)
|
(97)
|
(103)
|
(107)
|
(105)
|
(111)
|
(116)
|
(114)
|
(120)
|
(135)
|
(130)
|
(128)
|
|
Net Income (Common) |
34
N/A
|
39
+15%
|
43
+10%
|
44
+2%
|
64
+45%
|
129
+102%
|
166
+29%
|
183
+10%
|
199
+9%
|
157
-21%
|
158
+1%
|
158
N/A
|
164
+4%
|
180
+10%
|
190
+6%
|
210
+11%
|
224
+7%
|
232
+4%
|
237
+2%
|
259
+9%
|
258
0%
|
264
+2%
|
273
+3%
|
287
+5%
|
362
+26%
|
347
-4%
|
352
+1%
|
361
+3%
|
336
-7%
|
376
+12%
|
403
+7%
|
426
+6%
|
440
+3%
|
505
+15%
|
536
+6%
|
616
+15%
|
629
+2%
|
596
-5%
|
612
+3%
|
571
-7%
|
566
-1%
|
|
EPS (Diluted) |
0.05
N/A
|
0.06
+20%
|
0.06
N/A
|
0.06
N/A
|
0.09
+50%
|
0.14
+56%
|
0.2
+43%
|
0.22
+10%
|
0.23
+5%
|
0.17
-26%
|
0.19
+12%
|
0.19
N/A
|
0.19
N/A
|
0.2
+5%
|
0.22
+10%
|
0.24
+9%
|
0.26
+8%
|
0.26
N/A
|
0.23
-12%
|
0.28
+22%
|
0.24
-14%
|
0.26
+8%
|
0.28
+8%
|
0.28
N/A
|
0.35
+25%
|
0.33
-6%
|
0.33
N/A
|
0.34
+3%
|
0.32
-6%
|
0.36
+13%
|
0.39
+8%
|
0.42
+8%
|
0.42
N/A
|
0.49
+17%
|
0.45
-8%
|
0.51
+13%
|
0.47
-8%
|
0.48
+2%
|
0.48
N/A
|
0.44
-8%
|
0.44
N/A
|